Ageless Essentials
Ageless Essentials, licence 80095068: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Cellular Health Formula
- Licence holder
- Wesbrook Technologies
- NPN or DIN-HM
- 80095068
- Status
- Active licence
- Licence date
- 29 October 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| trans-3,5,4'-Trihydroxystilbéne Source : Resvératrol | 75.0 mg | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine | 190.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Silice, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | minimum: 2.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Source of antioxidants. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, proteins and fats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause nausea, abdominal pain, and/or diarrhea. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
- Précautions et mises en garde
If pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications.
Source
Official Health Canada record, licence 80095068
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.